Russia’s EnteroMix: First Personalized mRNA Cancer Vaccine in Clinical Testing
Russian health authorities are on the verge of introducing a breakthrough personalized cancer vaccine Russia has developed, named EnteroMix. Created by the National Medical Research Radiological Centre (NMRRC) in collaboration with leading Russian institutions including the Gamaleya Center, the vaccine represents a major mRNA oncology breakthrough and is now in Phase 1 clinical testing with […]
Russia’s EnteroMix: First Personalized mRNA Cancer Vaccine in Clinical Testing Read More »



